Skip to content
Radio Logo
PodcastsHealth & WellnessThis Week in Cardiology

This Week in Cardiology

Medscape
Latest episode

429 episodes

  • This Week in Cardiology

    Nov 13, 2026 This Week in Cardiology

    13/11/2026 | 34 mins.
    Listener feedback on the PROGRESS trial, the first Factor XI inhibitor improved, left bundle branch pacing, and statin discontinuation in older adults are the topics John Mandrola, MD, discusses in this week’s podcast.
    This podcast is intended for healthcare professionals only.
    To read a partial transcript or to comment, visit:
    https://www.medscape.com/twic
    I Listener Feedback
    PROGRESS Trial https://www.nejm.org/doi/abs/10.1056/NEJMoa2607326
    II FDA Approves Asundexian in Stroke
    Will FDA-Approved Factor XIa Change Secondary Stroke Prevention? https://www.medscape.com/viewarticle/will-fda-approved-factor-xia-change-secondary-stroke-2026a100177u
    OCEANIC-STROKE Trial https://www.nejm.org/doi/10.1056/NEJMoa2513880
    Bleeding With Asundexian vs Placebo in Patients With Ischemic Stroke or High-Risk TIA https://pubmed.ncbi.nlm.nih.gov/42866879/
    OCEANIC-AF trial https://www.nejm.org/doi/full/10.1056/NEJMoa2407105
    III Another Weak Pacing RCT – OptimPacing
    The Best Pacing Strategy for AV Block: A Head vs Heart Analysis of The OptimPacing Trial https://www.medscape.com/viewarticle/best-pacing-strategy-av-block-head-vs-heart-analysis-2026a10016rn
    LEAP-Block Trial https://jamanetwork.com/journals/jama/fullarticle/2855975
    OptimPacing Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2612972
    IV STREAM Trial
    Statins Work in Older Adults, Statistics Be Damned: The STREAM Trial https://www.medscape.com/viewarticle/statins-work-older-adults-statistics-be-damned-stream-trial-2026a10016oo
    STREAM Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2606634
    STAREE Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2607314
    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
    Questions or feedback, please contact news@medscape.net

    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
  • This Week in Cardiology

    Nov 06, 2026 This Week in Cardiology

    06/11/2026 | 30 mins.
    The moderate aortic stenosis TAVR trial, blinded withdrawal in the DECISION digoxin trial, CTO-PCI vs no CTO-PCI 10-year results, and the P4 trial are the topics John Mandrola, MD, discusses in this week’s podcast.
    This podcast is intended for healthcare professionals only.
    To read a partial transcript or to comment, visit:
    https://www.medscape.com/twic
    I PROGRESS Trial
    PROGRESS Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2607326
    PROGRESS Trial Editorial https://www.nejm.org/doi/full/10.1056/NEJMe2613400
    Genereux Classification https://academic.oup.com/eurheartj/article/38/45/3351/4002776
    II Withdrawing Digoxin in the DECISION trial
    DECISION Trial Substudy https://academic.oup.com/eurheartj/article/47/38/5545/8674856
    DECISION Trial - Main Trial https://www.nature.com/articles/s41591-026-04406-6
    Efficacy and Safety of Digitalis Glycosides in HF: Meta-analysis https://jamanetwork.com/journals/jama/fullarticle/2848972
    RADIANCE trial https://www.nejm.org/doi/full/10.1056/NEJM199307013290101
    PROVED trial https://www.jacc.org/doi/10.1016/0735-1097(93)90403-N
    III DECISION CTO Trial at 10 Years
    DECISION-CTO Trial 10-Year Outcomes 10.1016/j.jacc.2026.10.068
    DECISION-CTO Main paper https://doi.org/10.1161/CIRCULATIONAHA.118.031313
    EURO-CTO trial https://eurointervention.pcronline.com/article/three-year-outcomes-of-eurocto-a-randomized-multicentre-trial-comparing-revascularization-and-optimal-medical-therapy-for-chronic-total-coronary-occlusions
    COMET-CTO trial https://pmc.ncbi.nlm.nih.gov/articles/PMC9868942/
    EXPLORE Trial https://www.ahajournals.org/doi/10.1161/JAHA.123.033556
    ORBITA-CTO trial https://www.jacc.org/doi/10.1016/j.jacc.2026.03.027
    IV The P4 Trial
    Coronary CT Angiography Cuts Procedural Time Relative to IVUS-Guided PCI https://www.medscape.com/viewarticle/coronary-ct-angiography-cuts-procedural-time-relative-ivus-2026a1001684
    P4 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2610771
    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
    Questions or feedback, please contact news@medscape.net

    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
  • This Week in Cardiology

    Oct 30 2026 This Week in Cardiology

    30/10/2026 | 32 mins.
    The ASPIRED syncope RCT, two studies in coronary artery calcium scoring, and the LEAP-Block trial of CSP vs RV pacing are the topics John Mandrola, MD, discusses in this week’s podcast.
    This podcast is intended for healthcare professionals only.
    To read a partial transcript or to comment, visit:
    https://www.medscape.com/twic
    I Syncope
    ASPIRED Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2605812
    REMOSYNCED Trial https://clinicaltrials.gov/study/NCT05066347
    II TWO CAC Studies
    Atherosclerosis in Young Adults and Risk of Mortality Over 30 Years https://jamanetwork.com/journals/jamacardiology/fullarticle/2855732
    Predictive Utility of CAC Score Added to PREVENT Score https://jamanetwork.com/journals/jama/fullarticle/2853347
    III Conduction System Pacing vs Standard RV Pacing for AV block
    LEAP-Block Trial https://jamanetwork.com/journals/jama/fullarticle/2855975
    Meta-analysis: CSP vs RV Pacing in Preserved or Mildly Reduced EF https://doi.org/10.1016/j.cjca.2026.04.009
    You may also like:
    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
    Questions or feedback, please contact news@medscape.net

    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
  • This Week in Cardiology

    Oct 23, 2026 This Week in Cardiology Podcast

    23/10/2026 | 32 mins.
    Listener feedback on the nonobstructive HCM trials, AI-enhanced visits, timing of non-culprit PCI in STEMI, new tricuspid valve intervention, and EP at a crossroads are the topics John Mandrola, MD, discusses in this week’s podcast.
    This podcast is intended for healthcare professionals only.
    To read a partial transcript or to comment, visit:
    https://www.medscape.com/twic
    I Listener Feedback
    Koelemen meta-analysis https://www.medrxiv.org/content/10.64898/2026.09.08.26362195v1.full.pdf
    Improving SCD Risk Stratification in HCM https://pmc.ncbi.nlm.nih.gov/articles/PMC11026183/
    II More on Nonobstructive HCM
    Communication on Post-Hoc Analysis of ODYSSEY (mavacamten)
    Mavacamten in Nonobstructive HCM 10.1016/j.jacc.2025.12.092
    III Complete vs Staged PCI in STEMI With Multivessel Disease
    Immediate vs Staged CR in Multivessel Disease and STEMI: Meta-Analysis https://doi.org/10.1016/j.jcin.2026.07.033
    Timing of Nonculprit PCI for STEMI and Multivessel Disease: Editorial https://doi.org/10.1016/j.jcin.2026.08.009
    COMPLETE Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1907775
    FLOWER MI Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2104650
    FRAME AMI Trial https://doi.org/10.1093/eurheartj/ehac763
    iMODERN Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2512918
    COCUA Trial https://doi.org/10.1016/j.ahj.2023.01.020
    MULTISTARS Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2307823
    OPTION STEMI Trial 10.1016/S0140-6736(25)01529-6 External Link
    CULPRIT SHOCK Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1710261
    BioVasc Trial Substudy https://eurointervention.pcronline.com/article/immediate-versus-staged-complete-revascularisation-in-patients-presenting-with-stemi-and-multivessel-disease
    Main BioVasc Trial 10.1016/S0140-6736(23)00351-3 External Link
    FULL REVASC Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2314149
    IV A Call to Action for Electrophysiologists
    Twenty Years at the Crossroads 10.1016/j.jacep.2026.09.023
    EP at a Crossroads - Josephson 2007 https://doi.org/10.1016/j.hrthm.2006.12.045
    EP at a Crossroads: A Revisit - Josephson 2016 https://doi.org/10.1016/j.hrthm.2016.07.024
    V FDA Approves Another Tricuspid Valve Repair System
    Press release https://www.edwards.com/newsroom/news/2026-10-21-fda-approval-of-edwards-lifesciences--pascal-preci
    TRIC I HF Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2606934
    CLASP II TR Trial https://pubmed.ncbi.nlm.nih.gov/42855029/
    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
    Questions or feedback, please contact news@medscape.net

    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
  • This Week in Cardiology

    Oct 16, 2026 This Week in Cardiology Podcast

    16/10/2026 | 33 mins.
    Some promising studies in amyloidosis, aficamten in nonobstructive HCM, costs of the microaxial flow pump in cardiogenic shock, and more on the VESALIUS trial of evolocumab are the topics John Mandrola, MD, discusses in this week’s podcast.
    This podcast is intended for healthcare professionals only.
    To read a partial transcript or to comment, visit:
    https://www.medscape.com/twic
    I Light Chain Amyloidosis – A Potentially Helpful Drug
    Anselamimab Does Not Reduce Light-Chain Amyloidosis Deaths
    https://www.medscape.com/viewarticle/anselamimab-does-not-reduce-light-chain-amyloidosis-deaths-2026a1000z79
    II Aficamten in Nonobstructive HCM: The ACACIA trial
    III Microaxial Flow Pump Cost Analysis of Danger Shock
    IV More on Evolocumab at ESC: Vesalius Trial Substudies
    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
    Questions or feedback, please contact news@medscape.net
    https://www.medscape.com/viewarticle/1003092

    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
More Health & Wellness podcasts
About This Week in Cardiology
This podcast delivers Dr. John Mandrola's summary and perspective on top news of the week that cardiologists can't miss. This podcast is intended for US health professionals only.
Podcast website

Listen to This Week in Cardiology, The Imperfects and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features
This Week in Cardiology: Podcasts in Family